Suppr超能文献

一项减少人工血液透析通路植入的政策评估。

Assessment of a policy to reduce placement of prosthetic hemodialysis access.

作者信息

Gibson K D, Caps M T, Kohler T R, Hatsukami T S, Gillen D L, Aldassy M, Sherrard D J, Stehman-Breen C O

机构信息

Department of Surgery (Vascular), University of Washington School of Medicine, and VA Puget Sound Health Care System, Seattle, Washington 98195-6410, USA.

出版信息

Kidney Int. 2001 Jun;59(6):2335-45. doi: 10.1046/j.1523-1755.2001.00751.x.

Abstract

BACKGROUND

The aim of this study was to evaluate the determinants of access patency and revision, including the effects of reducing the placement of prosthetic hemodialysis access.

METHODS

A retrospective cohort study of all hemodialysis accesses placed at the Veteran's Administration Puget Sound Health Care System between 1992 and 1999 was conducted. A policy was instituted in 1996 that maximized the use of autogenous hemodialysis access. The impacts of the policy change, demographics, and comorbid factors on access type and patency, were examined. Primary and secondary patency rates were examined using the Kaplan--Meier method, and factors associated with failure and revision were examined using Cox proportional hazard models and Poisson regression.

RESULTS

During the study, 104 accesses (61 prosthetic grafts and 43 autogenous fistulas) were placed prior to 1996, and 118 (31 prosthetic grafts and 87 autogenous fistulas) were placed after 1996. There was a significant increase in autogenous fistulas placed after 1996 (87 out of 118) compared with before 1996 (43 out of 104, P < 0.001). At one year, autogenous fistulas demonstrated superior primary patency (56 vs. 36%, P = 0.001) and secondary patency (72 vs. 58%, P = 0.003) compared with prosthetic grafts. After adjustment for age, race, side of access placement, and history of prior access placement, patients with a prosthetic graft were estimated to experience a 78% increase in the risk of primary access failure when compared with similar patients having an autogenous access [adjusted relative risk (aRR) = 1.78, 95% CI 1.21--2.62, P = 0.003)]. Similarly, the adjusted relative risk of secondary access failure for comparing prosthetic grafts with autogenous fistulas was estimated to be 2.21 (95% CI 1.38--3.54, P = 0.001). The adjusted risk of access revision was 2.89-fold higher for prosthetic grafts than for autogenous fistulas (95% CI 1.88--4.44, P < 0.001).

CONCLUSIONS

Autogenous conduits demonstrated superior performance when compared with prosthetic grafts in terms of primary and secondary patency and number of revisions. A policy emphasizing the preferential placement of autogenous fistulas over prosthetic grafts may result in improved patency and a reduction in the number of procedures required to maintain dialysis access patency.

摘要

背景

本研究旨在评估血管通路通畅性和翻修的决定因素,包括减少人工血管透析通路植入的影响。

方法

对1992年至1999年在退伍军人事务部普吉特海湾医疗保健系统进行的所有血液透析通路植入进行回顾性队列研究。1996年制定了一项政策,最大限度地使用自体血液透析通路。研究了政策变化、人口统计学和合并症因素对通路类型和通畅性的影响。使用Kaplan-Meier方法检查初次和二次通畅率,并使用Cox比例风险模型和泊松回归检查与失败和翻修相关的因素。

结果

在研究期间,1996年之前植入了104条通路(61条人工血管移植物和43条自体动静脉内瘘),1996年之后植入了118条(31条人工血管移植物和87条自体动静脉内瘘)。与1996年之前(104条中的43条)相比,1996年之后植入的自体动静脉内瘘显著增加(118条中的87条,P<0.001)。在一年时,与人工血管移植物相比,自体动静脉内瘘的初次通畅率(56%对36%,P=0.001)和二次通畅率(72%对58%,P=0.003)更高。在调整年龄、种族、通路植入侧和既往通路植入史后,与具有自体通路的类似患者相比,植入人工血管移植物的患者初次通路失败风险估计增加78%[调整后相对风险(aRR)=1.78,95%CI 1.21-2.62,P=0.003]。同样,将人工血管移植物与自体动静脉内瘘进行比较时继发性通路失败的调整后相对风险估计为2.21(95%CI 1.38-3.54,P=0.001)。人工血管移植物的通路翻修调整风险比自体动静脉内瘘高2.89倍(95%CI 1.88-4.44,P<0.001)。

结论

与人工血管移植物相比,自体血管在初次和二次通畅性以及翻修次数方面表现更优。强调优先植入自体动静脉内瘘而非人工血管移植物的政策可能会提高通畅性,并减少维持透析通路通畅所需的手术次数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验